Alstodt Lance's Form 4 filing
BioRestorative Therapies, Inc. (BRTX) · filed Jan 20, 2023
- Accession no.
- 0001567619-23-001056
- Filed
- Jan 20, 2023
- Trade date
- Jan 18, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $1.25K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Alstodt LanceCIK 0001756228 | Director, Officer (President, CEO, COB) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | Common Stock | PPurchaseAcquired | +200 | $3.13 | +$626 | 186,321 | Direct | |
| Jan 18, 2023 | Common Stock | PPurchaseAcquired | +100 | $3.10 | +$310 | 186,421 | Direct | |
| Jan 18, 2023 | Common Stock | PPurchaseAcquired | +100 | $3.09 | +$309 | 186,521 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.